Title of Invention

8-(ANILINO)-1-NAPHTHALENESULFONATE ANALOGS AND THEIR USE IN ANALYTE DETECTION ASSAYS

Abstract

A process for the preparation of an 8-(aniNno}- 1-naphthalenesutfonate (AN8) analog which is capable of reacting with 3-methyl-2-benzothiazoiinone hydrazone hydrochloride ^BTH). or an analog thereof said process comprising; (a) mixing 6-Amlno-1-naphthalenesuironle add with 2,6 dIethytanlllne-HCL salt and aniline In a Teflon vessel wherein the aniline is chosen fTom one of the following: 0) 4'-tert-butyl aniline. (11) 4'-isopropyianiilne: Oil)

Full Text

INTRODUCTION Field of the Invention The field of this invention is dye compositions, particularly dye compositions suitable for use in anaiyte detection assays, e.g. glucose detection assays. Background of the Invention Anaiyte detection in physiological fluids, e.g. blood or blood derived products, is of ever increasing importance to today's society. Anaiyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions. Analytes of interest include glucose for diabetes management, cholesterol, and the like. In response to this growing importance of anaiyte detection, a variety of anaiyte detection protocols and devices for both clinical and home use have been developed. Many of the protocols and devices that have been developed to date employ a signal producing system to identify the presence of the anaiyte of interest in a physiological sample, such as blood. For example, one glucose detection system employed today uses a signal producing system that includes glucose oxidase, horseradish peroxidase, meta[3-methyl-2-benzothiazolinone hydrazonejN-sulfonyl benzenesulfonate monosodium (MBTHSB) and 8-(anilino)-l-naphthalenesulfonate (ANS). See U.S. Patent No.5,563,031. When glucose is combined with the above signal producing system in the presence of oxygen, the following reaction takes place: preseirt tA positions 3', 4' or 5'. Hi^ subject invention also provides novel ANS analogs. Hie sid>ject ANS analogs are characterized by having at least one non-hyject invention^ the subject amdop will hn described first, followed by a discussion of the methods of using the subject analogs in analyte detection assays. Before the subject invention is described fiirther, it is to be understood that the invention is not limited to the particular embodiments of the invention described below, as variations of the particular embodiments may be made and still fall within the scope of the appended claims. It is also to be understood that the terminology employed is for the purpose of describing particular embodiments, and is not intended to be limiting. Instead, the scope of the present invention will be established by the appended claims. In this specification and the appended claims, singular references include the plural, unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood to one of ordinary skill in the art to which this invention belongs. ANS ANALOGS The invention provides novel ANS analogs. The subject ANS analogs are characterized in that they react with MBTH or analogs thereof in the presence of an oxidizing agent, a peroxidase and oxygen to produce a chromogenic, specifically a blue, reaction product that exhibits reduced drift. By "reduced drift" is meant that the reaction product produced upon combination of the subject ANS analog with MBTH (or an analog thereof) has a more stable reading compared with the reading drift observed upon reaction of ANS with MBTH, or the same MBTH analog, where the drift is measured over a period of 2 minutes from the start of the reaction. See the Experimental Section, infra, for a detailed protocol for measuring reading drift. The reading drift of the reaction products produced by the subject analogs is generally reduced by at least about 35%, usually at least about 60% and in many embodiments at least about 80%. Furthermore, the color yield provided by the reaction product produced by the subject analogs is often greater than that observed for ANS in many embodiments of the subject invention, where when the color yield is greater, the color yield can be at least 5 % greater, usually at least about 20 % and in many embodiments at least about 35 % greater. Color yield is determined according to the protocol provided in the Experimental Section, infra. The subject ANS analogs are characterized by having at least one non-hydrogen jubstituent present on their phenyl moieties. The number of non-hydrogen substituents present on the phenyl moiety may range from about 1 to 5, usually from about 1 to 3 and more usually from about 1 to 2. Any convenient non-hydrogen group may be employed as the substituent on the phenyl group, so long as it provides for an ANS analog that exhibits the above described reduced drift characteristics. Generally, the non-hydrogen substituent(s) will reduce the aggregation tendencies of the dye product produced by the analog with MBTH (or analogs thereof). Representative non-hydrogen substituents include: alkyls (substituted and/or branched), aryls (substituted or unsubsituted), halogens, OR, SeR, SR and SiR, where R is an alkyl or aryl group that may be substituted and/or branched. Of particular interest are alkyl substituents, particularly lower alkyl substituents of 1 to 6 carbon atoms, usually 1 to 4 carbon atoms, where the alkyl substituents may be straight chained or branched. Alkyl substituents of particular interest include: methyl, isopropyl and /er/-butyl. In certain embodiments, the subject analogs are further limited in that when the substituent on the phenyl moiety is a metiiyl group, it is not bonded to the 3', 4' or 5' position of the phenyl moiety. In many embodiments, the subject analogs are described by the structural formula: SO,H ^^ wherein: n is an integer from 1 to 5, usually I to 3 and more usually 1 to 2; and each X is independently a non-hydrogen substituent, where suitable substituents include those identified supra, where in many embodiments each X is an alkyl, typically a lower Ukyl of 1 to 6, usually 1 to 4 carbon atoms, either straight chained or branched. As discussed rfjove, in certain preferred embodiments, each X is either methyl, isopropyl or rert-butyl. In ;ertain embodiments, if X is methyl, it is not located at the 3', 4' or 5' position of the phenyl noiety. Of particular interest are the following ANS analogs: 8-(4'-/er/-butylphenyl)amino-l-naphthalenesulfonate;8-(4'-isopropylphenyl)amino-I-naphthalenesulfonate;8-(2'-ter/-butylphenyl)amino-l-naphthalenesulfonate;8-(3',5'-di-rer/-butylphenyl)amino-l-naphthalenesulfonate; 8-(4'-methylphenyl)amino-l-naphthalenesulfonate; and 8-(2'-methylphenyl)amino-1 -naphthalenesulfonate. Of interest are the subject analogs in either their acid or salt form, where cations present in the salt form include: ammonium, sodium, potassium, calcium, magnesium, and the like. The above described ANS analogs of the subject invention may be prepared using any convenient protocol, where representative suitable protocols are provided in the Experimental section, infra. UTILITY The subject ANS compounds (either acid or salt form) find use in a variety of different applications as indicators for the presence of oxidizing agents. In other words, the subject analogs fmd use as reagent members of signal producing systems which detect the presence of oxidizing agents. Oxidizing agents that may be detected using signal producing systems that include the subject analogs include: peroxides, e.g. hydrogen peroxide, cumene hydrogen peroxide, urea hydrogen peroxide, benzoyl peroxide; perborates, e.g. sodium, potassium; etc. The subject analogs are particularly suited for use as reagents in signal producing systems designed to detect the presence of an analyte in a sample, usually a physiological sample, e.g. blood or a blood product derived from whole blood. Analytes of interest that may be detected using signal producing systems that include the subject analogs include: glucose, cholesterol, uric acid, alcohols (e.g. methanol, ethanol), formaldehyde, giycerol-3-phosphate, and tiie like. Of particular interest is the use of the subject analogs in signal producing systems designed to detect the presence of glucose in a physiological sample, particularly whole blood. The signal producing systems of which the subject analogs are members typically iurther include: an oxidase, a peroxidase and a second member of a dye couple (in which one of the subject ANS analogs is the first member). The oxidase that is present in the signal producing system is generally chosen depending on the nature of the analyte to be detected, where suitable oxidases include: glucose oxidase, cholesterol oxidase, uricase, alcohol oxidase, aldehyde oxidase, glycerophosphate oxidase, and the like. Peroxidases that may be members of the signal producing system include: horseradish peroxidase, other enzymes and synthetic analogs having peroxidative activity or oxidizing chemicals and the like. See e.g., Y. Ci, F. Wang; Analytica Chimica Acta, 233 (1990), 299-302. The second member of the dye couple of the signal producing system, of which the subject ANS analogs are the first member, is generally MBTH or an analog thereof Suitable MBTH analogs that may be employed as members of the subject signal producing systems include those described in U.S. Patent Nos. 5,922,530; 5,776,719; 5,563,031; 5,453,360 and 4,962,040, the disclosures of which are herein incorporated by reference. Of particular interest are the following MBTH analogs: meta[3-methyl-2-benzothiazolinone hydrazone]N-sulfonyl benzenesulfonate monosodium(MBTHSB), 3-methyl-2-benzothiazoIinone hydrazone hydrochloride(MBTH), 3-methyl-6-{sodium sulfonate)benzothiazolinone-2-hydrazone, 6-hydroxy-3-methyl-2-benzothiazolinonehydrazone, 4-hydroxy-3-methyl-2-benzothiazolinone hydrazone, and 6-carboxyl-3-methyl-2-benzothiazolinone hydrazone. In detecting an analyte by using a signal producing system of which the subject analogs are members, particularly members of a dye couple, as discussed above, a sample suspected of comprising the analyte of interest (i.e. the target analyte), usually a physiological sample, e.g. whole blood or a blood derived product, is contacted with the members of the signal producing system, either sequentially or at the same time. The presence of analyte results in the production of an oxidizing species, such as hydrogen peroxide, and a chromogenic reaction product is produced by covalent bonding of the two dye couple members of the above described signal oroducing system. The chromogenic reaction product is generally a blue reaction product, which is characterized by low drift in certain assay configurations (e.g. the SureStep® assay configuration) as described above. The presence of the chromogenic product is then related to he presence of analyte in the initial sample, where one may make qualitative or quantitative ieterminations of the amount of analyte in the original sample. Signal producing systems comprising the subject analogs are particularly suited for use n analyte detection assay devices in which the members of the signal producing system are tresent on a porous support, e.g. a strip, onto which the sample is placed and fi"om which the ignal is read. Representative devices in which the subject analogs find use include those lescribed in: 4,734,360; 4,900,666; 4,935,346; 5,059,394; 5,304,468; 5,306,623; 5,418,142; ,426,032; 5,515,170; 5,526.120; 5,563,042; 5,620,863; 5,753,429; 5,573,452; 5,780,304; 5,789,255; 5,843,691; 5,846,486; and the like, the disclosures of which are herein incorporated by reference. The following examples are offered by way of illustration and not by way of limitation. EXPERIMENTAL I. Synthesis of ANS analogs A. 4'-ter/-Butyl ANS ammonium salt 8-Amino-l-naphthalenesulfonic acid (1.53g), 4'-ter/-butyl aniline (3.60g) and 2,6- diethylaniline-HCI salt (0.95g) were mixed in a Teflon vessel, and the vessel was sealed after it was purged with N^, The vessel was then enclosed in a Parr bomb, and the bomb was placed in an oven and heated at leS'C for 18 hrs. The mixture was re-stirred and heated for an additional 15 hrs. After the reaction was complete, the bomb was cooled in an ice bath. The mixture was transferred to a beaker and dissolved in ethyl acetate. Purification was done by chromatography (A column packed with Silica Gel 60 GF2J4) with ethyl acetate as the eluent. Preparation of 4'-terr-butyI ANS ammonium salt: 4'-/er/- butyl ANS was dissolved in a mixed solvent of ethanol and ethyl acetate. Aqueous NH4OH solution was added to the compound and the solvent was evaporated to give light yellow crystalline solids. Some dark red impurity was removed by rinsing the solid product with ethanol. B. 4'-Isopropyl ANS ammonium salt 8-Amino-l-naphthalenesulfonic acid (1.53g), 4'-isopropyIaniline(3.60g) and 2,6- diethyianiline-HC! salt (0.95g) were mixed in a Teflon vessel, and the vessel was sealed after it was purged with N2. The vessel was then enclosed in a Parr bomb, and the bomb was placed in an oven and heated at 165 "C for 18 hrs. The mixture was re-stirred and heated for an additional 15 hrs. After the reaction was complete, the bomb was cooled in an ice bath. The mixture was transferred to a beaker with the help of 2-propanol rinse. (Normally, a significant amount of crystalline product was observed which could be re- crystallized to the corresponding ammonium salt). Purification was done by chromatography (a column packed with Silica Gel 60 GF254) with ethyl acetate as the eluent. Preparation of 4'-Isopropyl ANS ammonium salt: 4'-Isopropyl ANS was dissolved in a mixed solvent of ethanol and ethyl acetate. Aqueous NH4OH solution was —-^w vw «it wouipouna ana the solvent was evaporated to give light yellow crystalline solids. Some dark red impurity was removed by rinsing the solid product with ethanol. 2'-rerr-Butyl ANS ammonium salt 8-Amino-l-naphthalenesulfonic acid (l,53g), 2'-/err-butyl aniline (3.60g) and 2,6-diethylaniline-HCl salt (0.95g) were mixed in a Teflon vessel, and the vessel was sealed after it was purged with N^. The vessel was then enclosed in a Parr bomb, and the bomb was placed in an oven and heated at 195 "C for 48 hrs. The mixture was re-stirred and heated for an additional 48 hrs. After the reaction was complete, the reaction was cooled in an ice bath. The mixture was transferred to a beaker and dissolved in ethyl acetate. Purification was done by chromatography (a column packed with Silica Gel 60 GF2i4) with ethyl acetate as the solvent. Preparation of 2'-rer/-butyl ANS ammonium salt: 2'-/er/-butyl ANS was dissolved in a mbced solvent of ethanol and ethyl acetate. Aqueous NH4OH solution was added to the compound and the solvent was evaporated to give light yellow crystalline solids. Some dark red impurity was removed by rinsing the solid product with ethanol. 3',5'-Di-ter/-butyl ANS ammonium sah 8-Amino-l-naphthalenesulfonic acid (1.53g), 3', 5'-di-/er/-butyi aniline (3.80g) and 2,6-diethylaniline-HCl salt (0.95g) were mixed in a Teflon vessel, and the vessel was sealed after it was purged with Nj. The vessel was then enclosed in a Parr bomb, and the bomb was placed in an oven and heated at 190 "C for 24 hrs. The mixture was re-stirred and heated for an additional 24 hrs. After the reaction was complete, the bomb was cooled in an ice bath. The mixture was transferred to a beaker and dissolved in ethyl acetate. Purification was done by chromatography (a column packed with Silica Gel 60 GFzs^) with ethyl acetate as the solvent. Preparation of (3, 5'-Di-tert-butyl) ANS ammonium salt: (3,5'-Di-tert-butyl) ANS was dissolved in a mixed solvent of ethanol and ethyl acetate. Aqueous NH4OH solution was added to the compound and the solvent was evaporated to give light yellow crystalline solids. II. Testing of ANS analogs The above synthesized ANS analogs were tested as follows: A. Preparation of Test Strips The porous side of a 035^m polysulfone membrane (reaction matrix - obtained from U. S. Filter, San Diego, CA) is submerged in the aqueous dip shown in Table 1 until saturated. It is removed from the dip and the excess reagent is squeezed off with a glass rod. The strip is then hung inside an air circulating oven at 56°C for about 10 minutes, after which time the strip is removed and dipped into the organic dip described in Table 2 until saturated. It is then dried again as in the previous step. The resulting strip is fashioned into the desired shape for testing. K/S= K/S is a measure of reflectance, discussed and defined in USP 4,935,346, col. 14, the disclosure of which is herein incorporated by reference Max. K/S= maximum value of K/S during 2 minutes of measurement. % K/S= [(Max K/S of analog)/(Max K/S of ANS)] x 100 60s K/S= K/S @ 660 nm taken 60 sec after application of blood to the strip % drift = [(K/S Max-60s K/S)/(K/S max)] x 100 III. Results It was found that when the ANS analogs of the subject invention were employed in a glucose assay as described in II, supra, reduced drift was observed in the dye product, as compared with systems in which ANS is employed. Furthermore, the color yield was increased as compared with systems in which ANS is employed. Finally, 4'-rer/-butyl ANS was found to reach the completion of the reaction faster than ANS or the other ANS analogs that were tested. It is evident from the above results and discussion that the subject invention provides a number of advantages as compared to ANS when used in a signal producing system that fiirther includes MBTH (or analogs thereof). These advantages include reduced drift and increased color yield. Furthermore, the subject analogs are suitable for use with a broader range of MBTH analogs than is ANS. As such, the subject invention represents a significant contribution to the art. All publications and patents cited in this specification are herein incorporated by reference as if each individual publication or patent were specifically and individually indicated to be incorporated by reference. TTie citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims. 1. A process for the preparation of an 8-(aniNno}- 1-naphthalenesutfonate (AN8) analog which is capable of reacting with 3-methyl-2-benzothiazoiinone hydrazone hydrochloride ^BTH). or an analog thereof said process comprising; (a) mixing 6-Amlno-1-naphthalenesuironle add with 2,6 dIethytanlllne-HCL salt and aniline In a Teflon vessel wherein the aniline is chosen fTom one of the following: 0) 4'-tert-butyl aniline. (11) 4'-isopropyianiilne: Oil) 2'-tert-butyt aniline, or CIV) 3',5'-di-tert-butyl aniline; (b) scaling the vessel alter purging it with N2; (c) heating the vessel in an oven; (d) re-stirring and additional heating: (e) cooling the sealed vessel in an ice bath; (t) transferring the contents of the vessel to a beaicer and dissolving in ^hyl acetate; (g) purifying by chromatography; (h) dissolving the ANS with a mixed solvent of ethanol and ethyt acetate; (i) adding NH4OH solution to the compound and evaporating; and (j) removing any dailc red impurity with ethanol; wherein said process produces a dye product having reduced dritl as compared to the dye product produced upon reaction of ANS and MBTH or an analog thereof, wherein said ANS analog comprises at least one aikyi substituent bonded to the phenyl moiety, with the proviso that when said substituent is methyl, said substituent is not present at positions 3', 4' or 5*. 2. The process according to claim 1, wherein said alkyl substituent comprises 1 to 6 carbon atoms and Is branched or linear. 3. The process according to claims 1 or 2. wherein said analog is described by the formula: Wherein: nis 1 to 5; and X is independently an aUcyi group of from 1 to 6 carbon atoms, witti ttie proviso ihaH when X is at position 3',4' or 5', X is not mettiyl. 4. Tti8 process according to claim 3, wherein said atkyt group is methyl, isopropvl or tert-liuty). 5. A process for the preparation of a reaction product produced by a compound according to any of claims 1 to 4 and 3 -methyl-2 benzothiazolinone hydrazone hydrochloride (MBTH) or an MBTH analog, wherein said reaction product has a reduced drift as compared to the reaction product produced upon reaction of ANS and MBTH or the MBTH analog. 6. A process for the preparation of a composition of matter comprising a reaction product according to claim 5. 7. The process aceording to claim 6. wherein sakt reaction product Is present on t porous substrate. 8. The process according to claim 7. wherein said composition of matter further comprises an oxidase and a peroxidase. 9. The process of preparing an 8-(anlllno)-1-naph!halene5ulfonate (ANS) analog substantially as herein before described. 10. A method of producing a chromogenic reaction product, said method comprising: reacting a compound according to any of claims 1 to 4 with IMBTiH or an analog thereof In the presence of oxygen, hydrogen peroxide and peroxidase. 11. A method for detecting the presence of an anaiyte in a sample in which a dye couple comprising IMBTIH or an analog thereof and as second dye compound are employed, the improvement comprising; employing as said second dye compound a compound according to any of claims 1 to 4. 12. A method of producing a chromogenic reaction product substantially as herein before described.

Documents:

in-pct-2002-0536-che claims.pdf

in-pct-2002-0536-che correspondnece-others.pdf

in-pct-2002-0536-che correspondnece-po.pdf

in-pct-2002-0536-che description(complete).pdf

in-pct-2002-0536-che form-1.pdf

in-pct-2002-0536-che form-13.pdf

in-pct-2002-0536-che form-19.pdf

in-pct-2002-0536-che form-3.pdf

in-pct-2002-0536-che form-5.pdf

in-pct-2002-0536-che pct.pdf